Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This experimental, randomized study aims at evaluating the preventative effect of a Sun Protection Factor (SPF) 50+ sunscreen (Anthelios UVMUNE 400 Fluid SPF 50+) with high Ultraviolet A (UVA) protection on clinical signs of skin aging.
The study will be conducted in compliance with the protocol, current internal procedures and in the spirit of the International Council on Harmonisation (ICH) Topic E6(R2)5 ref: EMA/CHMP/ICH/135/1995, ICH Good Clinical Practice (GCP) Addendum Nov 2016 and applicable regulatory requirement.
Statistical plan: Tx represents the values observed at Time x, for each parameter and by subgroup. Quantitative variables, or those that can reasonably be treated as such, will be summarized using the minimum, maximum, measures of central tendency such as the mean and median & measures of dispersion such as the standard deviation (SD). Qualitative variables will be summarized in the form of counts and percentages.
For each parameter, a graphical representation of the means ±95% Confidence Interval (CI) will be produced to visually assess the evolution across time, by treatment group.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tested product group | Experimental | Volunteers using the investigational product handed over to them |
|
| Control group | Active Comparator | Volunteers using their own sun protection routine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tested product group | Other | Apply the test product per zone at least twice a day on the face, neck (neck & nape), décolleté and back of the hand in the morning and at midday whatever the weather conditions and the activities of the day |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the dermatological assessment of skin signs on the face (Global score) | Assessment of the skin parameters: Skin roughness [absent (0), mild (2), moderate (4), severe (6)]; Skin laxity [absent (0), mild (2), moderate (4), severe (6)]; Skin suppleness [high(0), moderate (2),low (4), absent (6)]; Skin radiance [highly radiant (0), radiant (2), normal(4), dull(6), highly dull(8)]; Pigmented spots [absent (0), visible (2), highly visible (4)]; Skin tone homogeneity [homogeneous (0), non-homogeneous (2)]. | Day0; Day84; Day168; Day252; Day336 |
| Measure | Description | Time Frame |
|---|---|---|
| Dermatological assessment of skin signs on the face - Atlas Bazin, Flament (Global score) | Assessment of the skin parameters: Forehead wrinkles (0 - 5); Crow feet wrinkles number (1 - 4); Crow feet wrinkles deepness (1 - 6); Glabellar wrinkles (0 - 5); Glabellar fine lines (0 - 5); Underneath eye wrinkle (0 - 5); Corner mouth wrinkle (0 - 6); Nasolabial fold (0 - 5); Upper lip wrinkles (0 - 6); Neck fold (0 - 5); Neck sagging (0 - 5); Ptosis (0 - 5); Eye bags (0 - 5 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Renato Moura | Contact | (55) 21 2221 6180 | renato.moura.b@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Renato Moura | Centre International de Développement Pharmaceutique | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CIDP | Recruiting | Rio de Janeiro | 20231-048 | Brazil |
Not provided
| ID | Term |
|---|---|
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control group | Other | Maintain their normal routine of using cosmetics (cleansers and moisturizers) and normal sun protection habits (if applicable) |
|
| Day0; Day84; Day168; Day252; Day336 |
| D008722 | Methods |